Advertisement
Engadget
Why you can trust us

Engadget has been testing and reviewing consumer tech since 2004. Our stories may include affiliate links; if you buy something through a link, we may earn a commission. Read more about how we evaluate products.

‘Hollow Knight: Silksong’ delayed and there's no updated release window

It was supposed to launch during the first half of this year.

Team Cherry

Hollow Knight: Silksong, the long-awaited sequel to 2017’s indie blockbuster Hollow Knight, has been delayed, as announced by Team Cherry developer Matthew Griffin on Twitter. The sidescrolling metroidvania platformer was scheduled for release in the first half of 2023, but, well, it’s May, so that isn’t happening. Additionally, the company hasn’t provided an updated release window.

“Development is still continuing. We're excited by how the game is shaping up, and it's gotten quite big, so we want to take the time to make the game as good as we can,” wrote Matthew Griffin.

Silksong was originally announced in early 2019 and hands-on gameplay demos followed in June, so folks naturally assumed that the game was close to launch. Time marched on with no real updates until last year when it was announced that Silksong would launch on Xbox Game Pass, in addition to just about every other platform. At that time, Xbox corporate vice president Sarah Bond said that the sequel would release by June of this year.

Like another long-delayed sequel, Silksong was originally conceived as a simple expansion to Hollow Knight with the game’s occasional antagonist Hornet acting as the main character. Since then, the game has apparently gotten much more ambitious. Team Cherry says it’ll release more details as we get closer to release.

Whenever it finally graces us with its presence, Hollow Knight: Silksong will launch on Nintendo Switch, PlayStation 4, PlayStation 5, Windows PC, Xbox One and Xbox Series X, with Game Pass availability from day one. In the meantime, there is no shortage of metroidvania games out there to hold you over.